Description

Description

Galza-Met (50/500mg) is a dual-action tablet that combines two well-established anti-diabetic medicines, Vildagliptin and Metformin, into a single dose for the management of type 2 diabetes mellitus. Each pack contains 14 tablets intended for oral use. This combination works through two complementary mechanisms: Vildagliptin, a DPP-4 inhibitor, helps preserve natural incretin hormones that boost insulin release and reduce glucagon activity, while Metformin, a biguanide, works by reducing glucose production in the liver and improving the body’s sensitivity to insulin. Together, these two approaches offer a more comprehensive strategy for blood sugar control than either medicine used individually. Manufactured by CCL Pharmaceuticals, Galza-Met 50/500mg is typically prescribed for patients whose diabetes has not been adequately managed on Metformin alone, or for those transitioning from taking both medicines separately to a single combined tablet, always under the guidance of a physician.

Ingredients

Each Galza-Met (50/500mg) tablet contains two active pharmaceutical ingredients: Vildagliptin at a strength of 50mg, and Metformin Hydrochloride at a strength of 500mg. Vildagliptin belongs to the DPP-4 inhibitor class and works by increasing the availability of incretin hormones that support insulin release and reduce glucagon secretion. Metformin belongs to the biguanide class and works primarily by decreasing hepatic glucose production, reducing intestinal glucose absorption, and improving peripheral insulin sensitivity. The tablet also contains standard pharmaceutical-grade excipients, including fillers, binding agents, and disintegrants, along with a film coating that supports ease of swallowing. The complete excipient list can be reviewed on the package insert or confirmed with a pharmacist, particularly for patients with known sensitivities to specific ingredients.

Dosage Form

Galza-Met (50/500mg) is supplied as a film-coated oral tablet that combines both active ingredients into a single dosage unit. Each pack contains 14 tablets, generally distributed across multiple strips, offering a convenient supply for patients on a twice-daily dosing schedule, as determined by their doctor. As a fixed-dose combination, it removes the need to take two separate tablets, helping simplify the daily treatment routine for patients managing type 2 diabetes.

Uses

Galza-Met (50/500mg) is used to help manage blood sugar levels in adults with type 2 diabetes mellitus who require the combined benefits of enhanced incretin activity and reduced hepatic glucose production. It is commonly prescribed for patients whose blood sugar has not been adequately controlled on Metformin alone, or for those who are already being treated with both Vildagliptin and Metformin as separate tablets and are switching to a more convenient combined formulation. By addressing blood sugar regulation through two distinct mechanisms, Galza-Met supports more effective glycemic control, which can help reduce the long-term risk of complications associated with poorly managed diabetes, including issues affecting the eyes, kidneys, nerves, and cardiovascular system.

How to Use

Galza-Met (50/500mg) should be taken exactly as prescribed by a doctor, typically as one tablet twice daily, taken with meals to help reduce the likelihood of gastrointestinal side effects associated with the Metformin component. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed unless specifically advised otherwise. Taking the medicine with food supports more predictable absorption and helps minimize stomach-related discomfort. Patients should not stop taking this medicine abruptly without medical advice, as diabetes management requires ongoing, consistent treatment. Regular blood sugar monitoring, along with periodic kidney and liver function tests, is generally recommended throughout the course of treatment to ensure the combination remains both safe and effective.

Side Effects

As a combination medicine, Galza-Met (50/500mg) may cause a range of side effects related to its two individual components. Commonly reported effects include gastrointestinal symptoms such as nausea, diarrhea, stomach upset, or a metallic taste in the mouth, which are often associated with the Metformin component and may improve with continued use. Effects linked to the Vildagliptin component can include headache, dizziness, and mild swelling, particularly in the hands or feet. Some patients may also experience joint discomfort or mild throat irritation. In rare cases, Metformin has been associated with a serious condition called lactic acidosis, particularly in patients with kidney or liver impairment, while Vildagliptin has rarely been linked to liver-related effects, both of which require prompt medical attention if symptoms such as unusual muscle pain, difficulty breathing, unexplained fatigue, or yellowing of the skin or eyes occur.

Pregnancy & Breastfeeding

Galza-Met (50/500mg) is generally not recommended for use during pregnancy, as blood sugar management in pregnant women with diabetes typically requires more precise, closely monitored control, often achieved through insulin therapy rather than oral combination medications. Women who are pregnant, planning to conceive, or who suspect they may be pregnant should inform their doctor promptly, as an alternative treatment approach is often considered safer under these circumstances. This medicine is also generally not advised during breastfeeding, as there is limited clarity on how the combined active ingredients may transfer into breast milk or affect a nursing infant. A healthcare provider should always be consulted before continuing or adjusting diabetes treatment during pregnancy or breastfeeding.

Storage Instructions

Galza-Met (50/500mg) tablets should be stored in a cool, dry place, away from direct sunlight and excessive humidity, ideally at normal room temperature. The tablets should remain in their original blister packaging until they are ready to be used, helping to preserve their stability and effectiveness. As with all medications, this product should be stored safely out of the reach and sight of children and pets. Tablets that have passed their expiry date should not be used, and any unused or expired medicine should be disposed of appropriately rather than discarded with regular household waste.

FAQs

Q: Why would a doctor prescribe a combination tablet instead of Metformin alone?
A: This combination is often prescribed when Metformin alone has not achieved adequate blood sugar control, allowing the added benefit of increased incretin activity from the Vildagliptin component.

Q: Should Galza-Met be taken with food?
A: Yes, it is generally recommended to take this medicine with meals to help reduce the risk of stomach-related side effects and to support more predictable absorption.

Q: Can Galza-Met cause low blood sugar?
A: The risk of hypoglycemia with this combination is relatively low, though it may increase if combined with other diabetes medications such as sulfonylureas or insulin.

Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, unless it is close to the time for your next dose, in which case skip it. Do not double the dose to make up for a missed one.

Q: Will I need regular check-ups while on this medicine?
A: Yes, your doctor will likely recommend periodic blood sugar monitoring, along with kidney and liver function tests, to ensure the medicine remains safe and effective for your treatment.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.